Renasant Corporation — Q2 2023 Form 10-Q
Business context and period: Regional banking and financial-services company operating across the Southeast, with nationwide factoring and asset-based lending. This unaudited report covers the quarter and six months ended June 30, 2023; comparisons are to the corresponding 2022 periods unless noted. Amounts below are in millions unless stated otherwise.
Financial performance and position
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Net interest income | $130.2 | $113.5 | $266.0 | $213.1 |
| Net interest margin, tax-equivalent | 3.45% | 3.11% | 3.56% | 2.94% |
| Noninterest income | $17.2 | $37.2 | $54.5 | $74.7 |
| Noninterest expense | $109.2 | $98.2 | $216.9 | $192.3 |
| Net income | $28.6 | $39.7 | $74.7 | $73.2 |
| Diluted EPS | $0.51 | $0.71 | $1.33 | $1.30 |
- Profitability and margins: Q2 net income fell about 28% year over year, principally reflecting a $22.4 million pretax loss on securities sales. Six-month net income increased about 2%. Higher loan yields and loan growth lifted net interest income, but the cost of funding rose sharply. The Q2 efficiency ratio was 72.63%, versus 64.37%; the filing says the securities loss increased the ratio by 9.44 percentage points.
- Balance sheet at June 30: Assets were $17.22 billion, loans held for investment net of unearned income were $11.93 billion, and total deposits were $14.10 billion. Since year-end 2022, loans grew about $352 million and deposits about $608 million. Shareholders’ equity was $2.21 billion; book value per share was $39.35.
- Funding, liquidity and debt: Noninterest-bearing deposits fell to $3.88 billion (27.52% of deposits) from $4.56 billion (33.80%) at year-end. Brokered deposits rose to $1.08 billion, an increase of about $848 million. Short-term borrowings declined to $257 million from $712 million; long-term debt was $430 million. Cash and cash equivalents were $946.9 million. Available FHLB borrowing capacity was $3.48 billion, with $180 million in unused lines at other banks.
- Cash flows for the six months: Operating activities used $31.5 million, compared with $349.7 million provided in 2022; investing activities provided $274.1 million, including $489.0 million in securities-sale proceeds; financing activities provided $128.3 million. Cash flow comparisons reflect substantial changes in mortgage-loan funding and sales and securities activity.
- Credit and capital: The allowance for loan losses was $194.4 million, or 1.63% of loans. Six-month net charge-offs were $8.6 million (0.15% annualized of average loans), versus $3.2 million (0.06%) in 2022. Nonperforming loans were $91.8 million, or 0.77% of loans, up from 0.49% at year-end; management attributed the increase mainly to two well-collateralized relationships and expected no loss. Company CET1 and total risk-based capital ratios were 10.30% and 14.76%; Bank ratios were 12.06% and 13.27%.
Material changes, outlook and risks
- Renasant sold securities with a carrying value of $511.4 million for $489.0 million proceeds, recording a $22.4 million loss. Management said proceeds were used to repay short-term FHLB borrowings. Available-for-sale securities were $950.9 million at fair value versus $1.53 billion at year-end; held-to-maturity securities had a fair value of $1.15 billion versus a $1.27 billion carrying value. Management stated that unrealized losses were not credit-related and that it did not expect to be required to sell affected securities before recovery or maturity.
- Management said industry-wide bank liquidity concerns prompted a decision to increase on-balance-sheet liquidity, including greater use of brokered deposits and borrowings. Deposit repricing and higher borrowing costs materially increased interest expense. Management continues to prioritize core deposits and cost control; the filing provides no specific earnings or margin guidance.
- Management described the balance sheet as asset-sensitive in its rate simulations: an immediate 100-basis-point increase was modeled to raise net interest income 3.45% over months 1–12 and 4.34% over months 13–24; a 100-basis-point decrease was modeled to reduce it 4.29% and 5.22%, respectively. These are scenario estimates, dependent on assumptions and not forecasts.
- Key disclosed risks include deposit competition and outflows, higher funding costs, banking-sector confidence and liquidity concerns, interest-rate and securities-value changes, loan-credit deterioration (including commercial real estate), and the uncertainty of credit-loss estimates. Estimated uninsured and uncollateralized deposits were $3.89 billion. Unfunded loan commitments were $3.27 billion and standby letters of credit $117.8 million.
- Other operating items: salaries and benefits and professional fees increased year over year; mortgage originations were lower amid higher rates. Consumer non-sufficient-funds and linked-account transfer fees were eliminated effective January 1, 2023. No material change in market risk or internal control effectiveness was reported; management said disclosure controls were effective.
Investor facts to verify
- Whether deposit mix, brokered funding and total funding costs stabilize, and how liquidity balances evolve.
- Whether the securities-sale loss is an isolated portfolio action and how remaining unrealized securities losses affect capital and flexibility.
- Whether nonperforming loans, particularly the two cited relationships and commercial real estate exposures, remain adequately collateralized and reserved.
- Whether loan growth and asset yields continue to offset deposit repricing, borrowing costs and elevated operating expenses.
- How actual net interest income responds relative to the filing’s rate-sensitivity scenarios, given their stated assumptions and limitations.